Skip to main content
. 2013 May 29;2013:289458. doi: 10.1155/2013/289458

Table 1.

Novel drugs for multiple myeloma bone disease.

Name of the drug Action Bone target cell/s
Denosumab RANKL neutralizing antibody OCs
LY2127399 BAFF neutralizing antibody OCs
MLN3897 CCR1 inhibitor OCs
BHQ880 DKK1 neutralizing antibody OBs
ACE-011 (sotatercept) Activin A neutralizing receptor OCs and OBs